• ქართული
  • English
  • Lilly to consider more acquisitions like $1.6 billion Armo buy

    Eli Lilly and Co will consider more acquisitions similar to its $1.6 billion purchase of cancer drug developer Armo Biosciences earlier this year, the drugmaker’s chief financial officer said on Tuesday.

    Market Quotes by TradingView